Stock listing

Intellia Therapeutics, Inc. (38I) Stock Price, News, Filings & Events

Selected listing: 38I · DUS · EUR · DE

This page tracks Intellia Therapeutics, Inc.'s 38I:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 38I:DUS. 38I:DUS is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to 38I:DUS. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.

website38I:DUSEURDESEO content: aiUpdated June 26, 2026/stock/dus-38i/intellia-therapeutics-inc/l-btgph1uxt2
Intellia Therapeutics, Inc. logo
Ticker
38I:DUS
Asset type
Stock
Market cap
$2.33B
Sector
Health Technology
Industry
Biotechnology
Exchange
DUS
Currency
EUR

Intellia Therapeutics, Inc. 38I:DUS stock context

This page tracks Intellia Therapeutics, Inc.'s 38I:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 38I:DUS. 38I:DUS is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to 38I:DUS. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.

Research Intellia Therapeutics, Inc.

Alternate listings